CCND1 and neoplasm: In the study of CCND1 ecDNA driving chemotherapy resistance, the authors found that CCND1 ecDNA significantly enhances tumor cell adaptation to chemotherapy by driving cell cycle progression through activation of the downstream E2F signaling pathway, demonstrating the fitness advantage of CCND1 ecDNA in driving resistance to chemotherapy.